Abstract:
OBJECTIVE To investigate the effect of isogliquiritin(ISL) on silicosis fibrosis induced by silica nanoparticles (SiNPs) and its molecular mechanism.
METHODS C57BL/6J mice were randomly divided into 5 groups: control group, model group, ISL low-dose group(5 mg·kg−1), ISL medium-dose group(10 mg·kg−1) and ISL high-dose group(20 mg·kg−1). A mouse silicosis model induced by SiNPs was established. After intervention with ISL, Hematoxylin-eosin(HE) and Masson staining were used to observe the degree of pulmonary inflammation and pulmonary fibrosis. The expression of fibrosis-associated alpha-smooth muscle actin(α-SMA) and collagen type I(Collagen I) was detected by immunohistochemistry. In order to further explore the potential molecular mechanism of ISL, the apoptosis-related proteins Bax and Caspase-3 were detected by immunohistochemistry and Western blotting. The A549 cell model stimulated by SiNPs was constructed. The survival rate of A549 cells was determined by MTT. The cells apoptosis rate was detected by flow cytometry FITC-Annexin V/PI fluorescence staining. The expressions of apoptotic proteins Bax and Caspase-3 were detected by Western blotting.
RESULTS In vivo, the results of HE and Masson staining showed that ISL intervention significantly improved SiNPs-induced lung injury and collagen fiber deposition. The expressions of α-SMA and Collagen I proteins were significantly inhibited, while the apoptosis-related proteins Bax and Caspase-3 expression were decreased. In vitro, ISL increased cell survival and decreased SiNPs-induced apoptosis, inhibited the expressions of Bax and Caspase-3 proteins.
CONCLUSION ISL alleviates SiNPs-induced pulmonary inflammation and fibrosis by inhibiting apoptosis, which provided a new idea for clinical treatment of silicosis fibrosis.